Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma

[1] Yang JC(2003)A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer N Engl J Med 349 427-434

[2] Haworth L(1990)Antiproliferative and antitumor effects of alpha interferon in renal cell carcinomas: correlation with the expression of a kidney associated differentiation glycoprotein Cancer Res 50 4190-4194

[3] Sherry RM(1987)Inhibition of angiogenesis by interferons: effects on tumor and lymphocyte induced vascular responses Cancer 47 5155-5161

[4] Hwu P(1993)The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis J Pediatr Surg 8 1253-1257

[5] Schwartzentruber DJ(1993)Interferon alfa-2a in advanced renal cell carcinoma: Treatment results and survival in 159 patients with long term follow-up J Clin Oncol 11 1368-1375

[6] Topalian SL(1996)Renal cell carcinoma N Engl J Med 335 865-875

[7] Steinberg SM(1998)Interferon gamma 1b compared with placebo in metastatic renal cell carcinoma N Engl J Med 338 1265-1271

[8] Chen HX(1998)Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal cell carcinoma N Engl J Med 338 1272-1278

[9] Rosenberg SA(2005)IMiDs: a novel class of immunomodulators Semin Oncol 32 S24-S30

[10] Nanus DM(1993)Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation J Exp Med 177 1675-1680

[1] Yang JC(2003)A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer N Engl J Med 349 427-434

[2] Haworth L(1990)Antiproliferative and antitumor effects of alpha interferon in renal cell carcinomas: correlation with the expression of a kidney associated differentiation glycoprotein Cancer Res 50 4190-4194

[3] Sherry RM(1987)Inhibition of angiogenesis by interferons: effects on tumor and lymphocyte induced vascular responses Cancer 47 5155-5161

[4] Hwu P(1993)The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis J Pediatr Surg 8 1253-1257

[5] Schwartzentruber DJ(1993)Interferon alfa-2a in advanced renal cell carcinoma: Treatment results and survival in 159 patients with long term follow-up J Clin Oncol 11 1368-1375

[6] Topalian SL(1996)Renal cell carcinoma N Engl J Med 335 865-875

[7] Steinberg SM(1998)Interferon gamma 1b compared with placebo in metastatic renal cell carcinoma N Engl J Med 338 1265-1271

[8] Chen HX(1998)Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal cell carcinoma N Engl J Med 338 1272-1278

[9] Rosenberg SA(2005)IMiDs: a novel class of immunomodulators Semin Oncol 32 S24-S30

[10] Nanus DM(1993)Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation J Exp Med 177 1675-1680